Cibra Capital LTD Chimerix Inc Call Options Transaction History
Cibra Capital LTD
- $293 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CMRX
# of Institutions
18Shares Held
7.43MCall Options Held
0Put Options Held
0-
Magnetar Financial LLC Evanston, IL3.92MShares$33.5 Million1.23% of portfolio
-
Jpmorgan Chase & CO New York, NY1.52MShares$13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY907KShares$7.74 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V894KShares$802,7590.0% of portfolio
-
Koshinski Asset Management, Inc.80KShares$683,1990.01% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...